G-protein coupled receptor 20 (GPR20)
Showing 1 - 25 of >10,000
Protein Metabolism Disorder Trial in Maastricht (20g whey protein drink ingestion, 20g native canola protein drink ingestion,
Recruiting
- Protein Metabolism Disorder
- 20g whey protein drink ingestion
- +3 more
-
Maastricht, Limburg, NetherlandsMaastricht University Medical Centre+
Sep 21, 2023
Obesity, Metabolic Syndrome, Metabolic Disorder Trial in Seville (Mediterranean diet supplement with 20 g / day of hemp
Completed
- Obesity
- +4 more
- Mediterranean diet supplement with 20 g / day of hemp protein.
-
Seville, SpainUniversity of Seville
Nov 8, 2023
Healthy Trial in Oxford (10 g NUTRALYS®S85 Plus pea protein, 20 g NUTRALYS®S85 Plus pea protein, 10 g Whey protein concentrate)
Completed
- Healthy
- 10 g NUTRALYS®S85 Plus pea protein
- +4 more
-
Oxford, United KingdomOxford Brookes Centre for Nutrition and Health
Sep 5, 2022
Multiple Myeloma Trial in New York (Infusion of MCARH109 T cells)
Active, not recruiting
- Multiple Myeloma
- Infusion of MCARH109 T cells
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jul 5, 2022
Carcinoma, Ductal, Breast, Breast Cancer, Breast Tumor Trial in Worldwide (G1T38, Fulvestrant)
Active, not recruiting
- Carcinoma, Ductal, Breast
- +2 more
-
Sofia, Bulgaria
- +7 more
Aug 1, 2022
Muscle Recovery Trial in Exeter (Recovery animal (20g whey) protein supplement, Recover vegan (26g pea) protein supplement,
Recruiting
- Muscle Recovery
- Recovery animal (20g whey) protein supplement
- +2 more
-
Exeter, United KingdomUniversity of Exeter
Mar 4, 2021
Heart Failure, Systolic Trial (Sodium lactate infusion, Sodium lactate ingestion)
Not yet recruiting
- Heart Failure, Systolic
- Sodium lactate infusion
- Sodium lactate ingestion
- (no location specified)
Nov 1, 2023
Metastatic Breast Cancer, FGFR 1 High Amplification, FGFR2 Amplification Trial in Worldwide (Futibatinib, Futibatinib plus
Recruiting
- Metastatic Breast Cancer
- +2 more
- Futibatinib
- Futibatinib plus Fulvestrant
-
Phoenix, Arizona
- +36 more
Jan 27, 2023
Metastatic Colorectal Cancer Trial in Worldwide (RO7122290, Cibisatamab, Obinutuzumab)
Recruiting
- Metastatic Colorectal Cancer
- RO7122290
- +2 more
-
Toronto, Ontario, Canada
- +15 more
Jan 13, 2023
Solid Tumor Trial in United Kingdom, United States (Farletuzumab ecteribulin)
Recruiting
- Solid Tumor
- Farletuzumab ecteribulin
-
Tucson, Arizona
- +26 more
Jan 30, 2023
Heart Failure, Systolic, Ketonemia Trial in Aarhus (Placebo NaCl, Niacin, Na-3-OHB)
Completed
- Heart Failure, Systolic
- Ketonemia
- Placebo NaCl
- +2 more
-
Aarhus, DenmarkAarhus University Hospital
Dec 2, 2021
Locally Advanced (Inoperable) or Metastatic Breast Cancer Trial in Worldwide (Capivasertib, Matched Capivasertib Placebo,
Recruiting
- Locally Advanced (Inoperable) or Metastatic Breast Cancer
- Capivasertib
- +3 more
-
Los Angeles, California
- +76 more
Nov 25, 2022
Genetic Causes of Kallmann Syndrome and Reproductive Disorders
Completed
- Hypogonadotropic Hypogonadism
- +4 more
-
Boston, MassachusettsMassachusetts General Hospital
Jun 29, 2022
Cardiomyopathy, Dilated, Heart Failure, Autoantibodies Trial in Belgrade, Belgrad (BC 007)
Active, not recruiting
- Cardiomyopathy, Dilated
- +2 more
- BC 007
-
Belgrade, Serbia
- +2 more
Jul 19, 2022
Renal Failure, Chronic Kidney Disease Requiring Chronic Dialysis Trial in Gainesville (Soy protein isolate, Whey protein
Recruiting
- Renal Failure
- Chronic Kidney Disease Requiring Chronic Dialysis
- Soy protein isolate
- Whey protein isolate
-
Gainesville, FloridaUniversity of Florida
Aug 7, 2022
NSCLC, NSCLC, Carcinoma, Bronchogenic Trial in United States (furmonertinib 240 mg, furmonertinib 160 mg, platinum-based chemo)
Recruiting
- Non-Small Cell Lung Cancer
- +13 more
- furmonertinib 240 mg
- +2 more
-
Yuma, Arizona
- +37 more
Dec 14, 2022
Breast Cancer, Non-small Cell Lung Carcinoma Trial in Worldwide (Trastuzumab deruxtecan (DS-8201a), Pembrolizumab)
Recruiting
- Breast Cancer
- Non-small Cell Lung Carcinoma
- Trastuzumab deruxtecan (DS-8201a)
- Pembrolizumab
-
San Francisco, California
- +24 more
Nov 30, 2022
Sleep, Inadequate Trial in Natick (Protein Nutrition During Recovery)
Not yet recruiting
- Sleep, Inadequate
- Protein Nutrition During Recovery
-
Natick, MassachusettsUS Army Research Institute of Environmental Medicine
Oct 4, 2023
Sarcopenia Trial in New Taipei City (HINEX Jelly ( jelly high protein supplement))
Active, not recruiting
- Sarcopenia
- HINEX Jelly ( jelly high protein supplement)
-
New Taipei City, Zhonghe Dist., TaiwanTaipei Medical University
Jun 28, 2023
Carcinoid Tumor of the Small Bowel, Neuroendocrine Tumour Trial in Worldwide (Octreotide LAR, 177Lu-DOTA0-Tyr3-Octreotate)
Completed
- Carcinoid Tumor of the Small Bowel
- Neuroendocrine Tumour
- Octreotide LAR
- 177Lu-DOTA0-Tyr3-Octreotate
-
Los Angeles, California
- +38 more
Mar 10, 2022